These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 16361212)

  • 1. Moral frameworks, ethical engagement and harm reduction: commentary on 'Ethical challenges and responses in harm reduction research: promoting applied communitarian ethics' by C. L. Fry, C. Treloar & L. Maher.
    Keane H
    Drug Alcohol Rev; 2005 Nov; 24(6):551-2. PubMed ID: 16361212
    [No Abstract]   [Full Text] [Related]  

  • 2. Applied communitarian ethics for harm reduction: promoting a dialogue within the field.
    Fry C; Treloar C; Maher L
    Drug Alcohol Rev; 2007 Sep; 26(5):553-5. PubMed ID: 17701519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ethical challenges and responses in harm reduction research: promoting applied communitarian ethics.
    Fry CL; Treloar C; Maher L
    Drug Alcohol Rev; 2005 Sep; 24(5):449-59. PubMed ID: 16298840
    [No Abstract]   [Full Text] [Related]  

  • 4. Harm reduction ethics: a promising basis for drug policy.
    Miller P
    Drug Alcohol Rev; 2005 Nov; 24(6):553-4. PubMed ID: 16361213
    [No Abstract]   [Full Text] [Related]  

  • 5. Ushering in another harm reduction era? Discursive authenticity, drug policy and research.
    Hathaway AD
    Drug Alcohol Rev; 2005 Nov; 24(6):549-50. PubMed ID: 16361211
    [No Abstract]   [Full Text] [Related]  

  • 6. Ethical challenges and responses in harm reduction research: a critique of applied communitarian ethics.
    Loff B
    Drug Alcohol Rev; 2006 Jul; 25(4):371-2. PubMed ID: 16854664
    [No Abstract]   [Full Text] [Related]  

  • 7. Strengthening drug policy and practice through ethics engagement: an old challenge for a new harm reduction.
    Irwin KS; Fry CL
    Int J Drug Policy; 2007 Mar; 18(2):75-83. PubMed ID: 17689348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How the harm reduction movement contrasts itself against punitive prohibition.
    Tammi T; Hurme T
    Int J Drug Policy; 2007 Mar; 18(2):84-7. PubMed ID: 17689349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. We still need communitarian ethics in harm reduction research.
    Mooney G
    Drug Alcohol Rev; 2006 Jul; 25(4):373-4. PubMed ID: 16854665
    [No Abstract]   [Full Text] [Related]  

  • 10. Using words: the harm reduction conception of drug use and drug users.
    Stafford N
    Int J Drug Policy; 2007 Mar; 18(2):88-91. PubMed ID: 17689350
    [No Abstract]   [Full Text] [Related]  

  • 11. Tobacco harm reduction: a call to address the ethical dilemmas.
    Fox BJ; Cohen JE
    Nicotine Tob Res; 2002; 4 Suppl 2():S81-7. PubMed ID: 12573170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of pleasure in harm reduction: perspectives from the history of sexuality.
    Race K
    Int J Drug Policy; 2008 Oct; 19(5):417-23. PubMed ID: 17904347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Harm reduction--an ethical imperative.
    Van Beek I
    Addiction; 2009 Mar; 104(3):342-3; discussion 345-6. PubMed ID: 19207339
    [No Abstract]   [Full Text] [Related]  

  • 14. The ethical, legal and social context of harm reduction.
    Pauly B; Goldstone I; McCall J; Gold F; Payne S
    Can Nurse; 2007 Oct; 103(8):19-23. PubMed ID: 17990401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug policy, harm and human rights: a rationalist approach.
    Stevens A
    Int J Drug Policy; 2011 May; 22(3):233-8. PubMed ID: 21481578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Engagement as an ethical imperative in harm reduction involving at-risk youth.
    Paterson BL; Panessa C
    Int J Drug Policy; 2008 Feb; 19(1):24-32. PubMed ID: 18164609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. From harm reduction to human rights: bringing liberalism back into drug reform debates.
    Hathaway AD
    Drug Alcohol Rev; 2002 Dec; 21(4):397-404. PubMed ID: 12537711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Virtue ethics as an alternative to deontological and consequential reasoning in the harm reduction debate.
    Christie T; Groarke L; Sweet W
    Int J Drug Policy; 2008 Feb; 19(1):52-8. PubMed ID: 18226518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dual use and the ethical responsibility of scientists.
    Ehni HJ
    Arch Immunol Ther Exp (Warsz); 2008; 56(3):147-52. PubMed ID: 18512027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Commentary: Understanding the origins of anger, contempt, and disgust in public health policy disputes: applying moral psychology to harm reduction debates.
    Alderman J; Dollar KM; Kozlowski LT
    J Public Health Policy; 2010 Apr; 31(1):1-16. PubMed ID: 20200522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.